Clinical Guides
Raynaud's Phenomenon
An India-contextualised, source-traceable guide to recognising Raynaud's phenomenon, distinguishing primary from secondary disease, and escalating threatened digital perfusion; it supports supervised clinical learning rather than self-treatment.
MedNext Academy | 12 min read
Raynaud's Phenomenon
An India-contextualised, source-traceable guide to recognising Raynaud's phenomenon, distinguishing primary from secondary disease, and escalating threatened digital perfusion; it supports supervised clinical learning rather than self-treatment.
Summary
Raynaud's phenomenon is episodic vasospasm of the digital circulation, usually provoked by cold or emotional stress. Pallor, cyanosis and reactive redness may occur in sequence, but a history of reversible, sharply demarcated colour change with sensory symptoms is more useful than demanding all three colours. Primary Raynaud's is usually symmetrical, begins in younger people, has normal pulses and nailfold assessment, and does not cause ulceration or tissue loss. Secondary Raynaud's is a sign rather than a final diagnosis: systemic sclerosis and other connective-tissue diseases, arterial disease, vibration exposure, medicines and stimulants are important alternatives. The first priority is to recognise persistent digital ischaemia, infection or necrosis, which needs urgent same-day hospital assessment. For uncomplicated attacks, whole-body warming, smoking cessation and trigger review are foundational. A long-acting dihydropyridine calcium-channel blocker is commonly first-line when symptoms remain functionally important. Treatment must be individualised for blood pressure, cardiovascular disease, pregnancy and interacting vasodilators; a tablet should never postpone investigation of a new ulcer, asymmetry or systemic disease. Attack diaries can document temperature, duration, affected digits, functional impact and response to measures, making a follow-up decision more reliable than recollection alone. Photographs may help show transient colour change, but they do not replace pulse examination or assessment of a painful non-blanching lesion. During an attack, remove rings early if swelling is possible and avoid direct high heat on an insensate hand, which can cause a burn. The clinical endpoint is preservation of viable, functional digits, not merely a reduction in reported attacks.
How Common Is It?
Raynaud's is common in cooler climates, but prevalence figures change markedly with latitude, season, case definition and whether surveys capture self-reported colour change or clinician-confirmed disease. It is therefore unsafe to transfer a European prevalence estimate to all of India. Primary disease is more frequent in women and often begins in adolescence or early adult life. The clinically important epidemiology is not the population percentage but the probability of secondary disease in the person in front of the clinician. Later onset, male sex, thumb involvement, unilateral or markedly asymmetric attacks, abnormal pulses, puffy fingers, nailfold abnormalities, inflammatory symptoms or fingertip damage increase concern. In India, cold exposure may be occupational, domestic or seasonal rather than limited to mountain regions; vibration-tool exposure in manufacturing, mining, construction and transport work should be actively elicited. Digital symptoms can also be amplified by tobacco or nicotine, sympathomimetics and fragmented access to rheumatology or vascular assessment. Frequency of attacks does not reliably measure danger: infrequent but persistent painful pallor in one digit can represent arterial occlusion rather than benign primary vasospasm.
Risk Factors
Ask what provokes an episode, how long it lasts, whether it is symmetrical and whether normal colour returns with warming. Cold, sudden temperature transition, stress and nicotine are common triggers. Review prescribed and non-prescribed exposures: non-selective beta blockers, vasoconstricting decongestants, stimulant medicines, ergot derivatives, some chemotherapy, cocaine and amphetamines may worsen vasospasm. Repeated hand-arm vibration requires an occupational history covering the actual tool, duration, grip and associated numbness or weakness; it may coexist with neuropathy or arterial injury. Secondary Raynaud's should be sought with a directed connective-tissue-disease review: puffy fingers, sclerodactyly, telangiectasia, digital pits, reflux or dysphagia, photosensitive rash, oral ulcers, inflammatory arthritis, sicca symptoms, proximal weakness, dyspnoea and thrombosis are useful clues. Consider peripheral arterial disease, embolic disease, thoracic outlet pathology, hypothyroidism, cryoprotein or paraprotein disorders only where the history and examination support them. Family history and a young age of onset can support primary disease but never exclude another condition. Pregnancy is a clinical context, not a cause to dismiss symptoms: assess maternal perfusion, blood pressure, underlying autoimmune disease and all current medicines before prescribing.
Diagnosis
History
Document the colour sequence, digits involved, duration, recovery with warmth, pain, numbness and effect on work or daily living. Ask specifically about ulcers, infection, previous thrombosis, migraine, chest symptoms, miscarriages and systemic features.
Examination
Observe skin colour and temperature, capillary refill, ulcers, pits, scars and gangrene. Palpate radial and ulnar pulses; examine for bruits and compare both arms. Look for skin thickening, puffy fingers, telangiectasia, arthritis, rash and proximal muscle weakness. Nailfold capillaroscopy, where available, helps distinguish a scleroderma-pattern microangiopathy from primary disease.
Investigations
Typical young-onset symmetrical primary disease with a normal examination may need little testing. When secondary disease is plausible, use targeted tests rather than indiscriminate autoantibody panels: full blood count, inflammatory markers, renal function, urinalysis, thyroid testing when indicated, antinuclear antibody with disease-specific follow-up, and capillaroscopy. Doppler or vascular imaging is urgent for persistent unilateral ischaemia or absent pulses. Pregnancy testing and obstetric/rheumatology input matter before changing vasodilators. A positive ANA alone is not a diagnosis; interpret it with phenotype, capillaroscopy and longitudinal review.
Differential Diagnosis
Acrocyanosis produces more persistent, usually painless bluish discolouration rather than discrete reversible attacks. Pernio causes inflammatory, itchy or painful cold-related lesions that persist for days. Erythromelalgia is a heat-triggered red, hot, burning syndrome, essentially the opposite physiological pattern. Peripheral arterial disease, embolism, vasculitis and thromboangiitis can cause asymmetrical painful ischaemia, abnormal pulses or fixed tissue injury; calling these Raynaud's can lose a limb. Carpal tunnel syndrome and peripheral neuropathy cause paraesthesia without a characteristic vasospastic colour change. Complex regional pain syndrome can alter colour and temperature but follows pain, swelling and autonomic disturbance rather than reproducible cold-provoked triphasic attacks. In connective-tissue disease, Raynaud's may precede other signs, particularly in systemic sclerosis, mixed connective-tissue disease, lupus and inflammatory myopathy. Hypothyroidism, cryoglobulinaemia and cold agglutinin disease are less common but reasonable to consider when compatible systemic findings exist. A cold painful digit with no prompt rewarming response should be treated as possible acute arterial insufficiency until proved otherwise.
Management
Explain the mechanism and agree a practical trigger plan: layer clothing, warm the core before hands, use gloves or mittens, warm footwear, avoid abrupt cold exposure, use hand warmers safely, and rewarm gradually. Stop smoking and nicotine exposure; review vasoconstricting medicines with the prescriber rather than stopping essential therapy abruptly. Exercise, stress-management and workplace adaptation can reduce attack burden. For primary Raynaud's that remains intrusive, a modified-release dihydropyridine calcium-channel blocker is reasonable after measuring blood pressure and discussing headache, flushing, ankle oedema, dizziness and palpitations. Titrate slowly and assess function, not only attack counts; seasonal treatment breaks can be considered if symptoms remit. Secondary Raynaud's requires treatment of the underlying condition and early specialist involvement. Refractory secondary disease, recurrent ulcers or ischaemia may require specialist-directed phosphodiesterase-5 inhibition, intravenous prostanoid therapy, wound care, infection treatment or selected procedures. Do not combine nitrate products with phosphodiesterase-5 inhibitors because severe hypotension can result. Analgesia, protection from trauma and rapid ulcer review are part of vascular care, not optional add-ons.
Prescribing Information
Nifedipine modified release is a common first pharmacological option, but local formularies and the individual product information determine the preparation and dose. A cautious example is 10 mg modified release daily, titrated according to response and blood pressure; some specialist pathways use up to 60 mg daily. Avoid immediate-release self-dosing for an attack. Check baseline hypotension, syncope, severe aortic stenosis, heart failure context, interacting antihypertensives and adverse effects before escalation. Amlodipine is an alternative in some pathways. In pregnancy, do not assume that a Raynaud's prescription is unsafe or safe by class alone: BSR guidance considers nifedipine compatible with pregnancy up to 90 mg/day, but the obstetric team should individualise the indication, formulation, maternal blood pressure and fetal context. Nitrates and sildenafil are specialist decisions for resistant or secondary disease; their combination is contraindicated because of profound hypotension. Sildenafil, prostanoids and endothelin-receptor antagonists have distinct pregnancy restrictions and specialist indications. Digital ulcers need wound and infection assessment; neither antibiotics nor vasodilators should be prescribed blindly without examining perfusion and tissue viability.
When to Refer
Refer non-urgently to rheumatology when symptoms begin after about 30 years, are severe or treatment-resistant, or when connective-tissue disease features, positive disease-relevant autoantibodies or abnormal capillaroscopy are present. Refer to vascular services when attacks are unilateral, pulses are reduced, there is a bruit, embolic risk, claudication or a fixed ischaemic lesion. Occupational-health referral is appropriate for suspected vibration-related disease, both to protect the patient and document preventable exposure. A patient with recurrent fingertip ulcers benefits from coordinated rheumatology, vascular, dermatology or wound-care input depending on local service design. In pregnancy, liaise with obstetrics and the specialist managing autoimmune disease before initiating or changing long-term vasodilator therapy. Referral is also reasonable when the diagnostic label is uncertain: persistent cyanosis, atypical pain or non-resolving lesions merit re-examination rather than repeated empirical prescriptions. Safety-net every referral with the signs that change the time scale: worsening pain, a cold fixed pale or blue digit, spreading redness, discharge, fever or black tissue require urgent assessment.
Red Flags
A persistently pale, blue or cold digit that does not recover promptly with gentle rewarming is possible critical digital ischaemia and requires same-day emergency vascular or hospital assessment. Severe escalating pain, absent or newly reduced pulses, unilateral onset, neurological deficit, trauma, embolic symptoms or widespread livedo make benign primary Raynaud's unlikely. Digital ulceration, pitting scars, gangrene or black tissue suggests established vascular injury; assess perfusion, obtain specialist advice and look for infection or osteomyelitis where clinically indicated. Fever, purulent discharge, spreading erythema or systemic illness around an ulcer needs urgent infection management alongside restoration of blood flow. New Raynaud's with skin tightening, puffy fingers, dysphagia, dyspnoea, inflammatory arthritis, rash, muscle weakness or renal/urinary abnormalities should trigger secondary-disease evaluation. Pregnancy with severe symptoms, hypertension, autoimmune disease or reduced fetal movements should follow obstetric pathways. Never reassure solely because the patient calls the episode Raynaud's: acute arterial occlusion and vasculitis can mimic it, and the consequence of delay is tissue loss.
Indian Clinical Context
India-wide prevalence and a single 'stone-belt style' geographic story for Raynaud's are not evidence-based. Teaching should instead focus on locally relevant exposures and access: cold rooms, high-altitude work and seasonal cold; two-wheeler travel; wet work; tobacco and smokeless nicotine; and hand-held vibrating equipment in construction, quarrying, manufacturing and informal work. Patients may use over-the-counter cold remedies or traditional products without recognising vasoconstrictor ingredients, so ask non-judgementally about all products. Examination-led triage is especially valuable where capillaroscopy, Doppler imaging and rheumatology are distant: document pulse symmetry, tissue loss and systemic clues, start warmth and nicotine cessation advice, and arrange referral rather than attempting to exclude systemic sclerosis using a single test. Generic brands and availability vary, so prescribe by generic name and formulation, and confirm the current CDSCO-approved product information and local hospital formulary. Pregnancy care should be coordinated with obstetrics; maternal hypotension or unrecognised connective-tissue disease is more important than forcing a uniform drug regimen. This guide does not endorse herbal vasodilators or unregulated supplements, because reliable efficacy, interaction and pregnancy-safety evidence is insufficient.
NMC Competency Mapping
This topic integrates competency-based clinical reasoning rather than claiming a single standalone undergraduate code. Learners should be able to take a focused vascular and autoimmune history, inspect and document peripheral perfusion, distinguish a reversible vasospastic syndrome from acute limb ischaemia, and identify when referral is urgent. It connects medicine competencies on connective-tissue disease, cardiovascular/peripheral vascular examination, pharmacology of vasodilators and adverse drug effects, dermatological assessment of ulcers, and obstetric principles of medicine use in pregnancy. A safe station answer states the working diagnosis and its uncertainty, checks pulses and tissue viability, asks about systemic sclerosis features and exposures, performs targeted rather than indiscriminate investigations, and gives explicit safety-net advice. For an NMC-aligned learner, 'primary versus secondary' is not a memorised list: it is a decision about whether the presentation can safely be observed or requires vascular/rheumatology assessment. Local colleges should map this guide to their current NMC curriculum implementation and assessment blueprint.
Key Exam Pearls for NEET PG
Raynaud's phenomenon is episodic digital vasospasm, classically white then blue then red, usually provoked by cold or stress. Primary disease is younger-onset, symmetrical and non-destructive; ulcers, pitting scars, late onset, asymmetry, abnormal pulses or systemic symptoms suggest secondary disease. Systemic sclerosis is the connective-tissue disorder most strongly associated with severe secondary Raynaud's and a scleroderma-pattern nailfold capillaroscopy. Acrocyanosis is persistent and usually painless, unlike attacks of Raynaud's. First management is trigger reduction, whole-body warming and nicotine cessation. Dihydropyridine calcium-channel blockers are the usual first pharmacological choice; prescribe modified-release nifedipine carefully and monitor hypotension-related adverse effects. Do not co-prescribe nitrates and a phosphodiesterase-5 inhibitor. A painful fixed pale or blue digit is an emergency vascular problem, not a routine outpatient attack. In systemic sclerosis-related severe digital vasculopathy, specialist therapies include phosphodiesterase-5 inhibitors and intravenous prostanoids; bosentan is used in selected patients to reduce new digital ulcers, not as a substitute for urgent treatment of threatened tissue.
Frequently Asked Questions
How can primary Raynaud's be distinguished from secondary disease?
Primary disease is a clinical pattern: younger onset, symmetric reversible attacks, normal pulses, no ulcers or pitting scars, normal nailfold assessment and no systemic illness. Secondary disease becomes more likely with later onset, male sex, asymmetry, thumb involvement, ulcers, fixed ischaemia, abnormal pulses or features of connective-tissue disease. No single blood test safely makes the distinction. The clinician combines history, examination, capillaroscopy where available and directed laboratory testing. A positive antinuclear antibody without compatible clinical features does not by itself establish lupus or systemic sclerosis. Conversely, normal initial tests do not make a persistently ischaemic digit safe. The question is whether an underlying disease or arterial obstruction needs active investigation, not whether every attack has all three classic colours. Review also provides diagnostic information. Primary symptoms may vary with weather and improve with protective measures, whereas new persistent attacks, increasing pain, ulceration, change in pulse or new systemic symptoms require reassessment even after an earlier reassuring evaluation. The records should state which digits are involved, whether thumbs are spared, pulse findings and the reason for any decision not to investigate. This prevents a historic label of primary Raynaud's from masking later systemic sclerosis, arterial disease or a medicine-related problem.
What should a person do during a typical Raynaud's attack?
Move to a warm environment, warm the trunk first, use gloves or lukewarm water and avoid sudden intense heat that can burn numb skin. Remove cold or wet items and avoid nicotine. Record triggers and duration if attacks are recurrent; photographs can help a clinician when the colour change has resolved before review. Do not use someone else's vasodilator or take extra doses for an isolated attack. Seek urgent assessment rather than continuing to warm at home if one or more digits remain cold, pale or blue, pain is severe or escalating, sensation or movement is impaired, pulses seem reduced, there is an ulcer, or the episode is clearly different from usual. Those features can indicate acute arterial insufficiency rather than uncomplicated vasospasm.
Is nifedipine safe for Raynaud's during pregnancy or breastfeeding?
Nifedipine can be compatible with pregnancy and breastfeeding, but that does not mean every formulation, dose or indication is automatically appropriate. The British Society for Rheumatology pregnancy guideline reports no direct evidence of harm with nifedipine at doses up to 90 mg daily, while product information and obstetric recommendations still require patient-specific review. Maternal blood pressure, dizziness or syncope, co-prescribed medicines, renal disease, the reason for treatment and fetal context matter. Do not start, stop or escalate vasodilators during pregnancy without the clinician and obstetric team who know the pregnancy. Drugs used for severe secondary Raynaud's, such as sildenafil, iloprost or endothelin-receptor antagonists, have different evidence and restrictions and require specialist management.
When does a fingertip ulcer need urgent clinical assessment?
Any new ulcer merits prompt assessment because it may reflect secondary vascular disease and can become infected. Same-day urgent review is needed for a cold fixed digit, severe or worsening pain, black tissue, rapidly spreading redness, pus, fever, swelling or reduced sensation or movement. The assessment should establish perfusion, tissue viability, infection and the underlying cause; antibiotics alone cannot correct critical ischaemia, while vasodilators alone do not treat abscess or osteomyelitis. People with systemic sclerosis or recurrent ulcers often need a coordinated plan for wound protection, analgesia, infection treatment and specialist vascular/rheumatology therapies. Avoid trauma and smoking, keep the wound protected and follow local wound-care advice while arranging review. Clinicians should record ulcer site, dimensions, base, surrounding erythema, drainage, pain, temperature, capillary refill and pulses, then compare at follow-up; a photograph in the clinical record can be useful with consent. Debridement, swabbing, radiography or other imaging are chosen when devitalised tissue, deep infection or osteomyelitis is plausible. Protecting hands from minor trauma, avoiding adhesive injury to fragile skin and ensuring prompt dressing review are practical components of care. A person should understand that ulcer closure is not the only outcome: prevention of another ischaemic episode, preservation of sensation and function, and recognition of systemic disease are equally important. Repeated antibiotic courses without perfusion assessment are unsafe.
Inside MedNext for this topic
- 411 MedNext-authored chapters
- 80,000+ MCQ bank
- 15 study modes
- a growing library of visual revision sheets
Study modes
- Notes
- MCQ
- Audio
- Video
- Visual
- 3D Anatomy
- Trace
- Flashcards
- Mnemonics
- Image Bank
- Clinical
- Microscopy
- Audio QBank
- Cadaver
- Book Match
Continue reading
Clinical GuidesAll Clinical Guides
Browse all clinical management guides for Indian medical practice.
Test your knowledge
Attempt structured MCQs on this topic to consolidate your understanding and connect the guide to exam-focused practice.
Try MCQs on this topic